2023, but that deadline has passed with no new guidance issued. “We’re really waiting for that guidance,” Aboelata said. “We’re waiting for that guidance to really set the standard.”
Ultimately, the hope is that the changes made in response to the lawsuit and pressure from advocates will lead to better devices that accurately measure blood oxygen levels in patients of all skin tones. The fight for health equity continues, and those like Aboelata and her team at Roots Community Health are at the forefront, pushing for change and holding companies accountable for the impact of their products on marginalized communities.
As we move forward, it is essential that we continue to address the systemic issues that contribute to health disparities and work towards a more equitable healthcare system for all.
The Food and Drug Administration (FDA) has announced that they are working diligently to issue new guidance for drug device manufacturers. This guidance will offer best-practice recommendations, although it is important to note that these recommendations are not requirements.
Dr. Aboelata, a spokesperson for the agency, expressed satisfaction with the progress made on this issue. However, he emphasized that fixing the machines is ultimately the most important aspect of the situation. He hopes that the new guidance will serve as a catalyst for raising awareness but acknowledges that there is still a long way to go before justice is served on this matter.
The FDA’s commitment to providing updated guidance shows their dedication to ensuring the safety and effectiveness of drug devices. By offering best practices, they aim to support manufacturers in producing high-quality products that meet regulatory standards.
It is essential for drug device manufacturers to adhere to these guidelines to protect the health and well-being of patients. The FDA’s efforts to provide comprehensive recommendations demonstrate their commitment to upholding the highest standards in the industry.
As the FDA continues to work on issuing the new guidance, stakeholders in the healthcare industry are encouraged to stay informed and compliant with the latest updates. By following best practices and guidelines, manufacturers can contribute to a safer and more effective healthcare system for all.
